" class="no-js "lang="en-US"> Sutro Biopharma - Medtech Alert
Friday, April 12, 2024
Sutro Biopharma | Pharmtech Focus

Sutro Biopharma

About Sutro Biopharma

Sutro Biopharma

At Sutro Biopharma, a clinical stage company, we have pioneered a compelling and unique way of discovering, developing and manufacturing therapeutics. Our focus is aimed primarily on next generation cancer therapeutics and autoimmune disease — Antibody Conjugates, Bispecific Antibodies and cytokine derivatives. Unconstrained by traditional methods of cell-based discovery, we can design and develop targeted medicines by innovating outside the constraints of the cell.

Related Story

Sutro Biopharma Announces Expansion of Leadership Team

September 17 2021

Sutro Biopharma, Inc. (NASDAQ: STRO), a clinical-stage drug discovery, development and manufacturing company focused on […]

Sutro Biopharma Appoints Jane Chung as Chief Commercial Officer

August 10 2021

Sutro Biopharma, Inc. (NASDAQ: STRO), a clinical-stage drug discovery, development and manufacturing company focused on the […]